Synapse - Katia Ventura

Results (24)

Retinoblastoma (Rb) protein in small cell lung carcinoma: Combined genomic and immunohistochemical analysis with a description of a rare Rb-proficient subset

Meeting Abstract

Febres-Aldana, C.; Baine, M.; Chang, J.; Ptashkin, R.; Gedvilaite, E.; Ventura, K.; Bodd, F.; Egger, J.; Travis, W.; Lai, W. C.; more...
Laboratory Investigation (2022)

Fulltext@MSK | Save

Unexpected histologic and molecular features in tumors of long-term survivors (LTS) of diffuse pleural mesothelioma (DPM)

Meeting Abstract

Baine, M.; Adusumilli, P.; Bodd, F.; Ladanyi, M.; Offin, M.; Travis, W.; Yang, S. R.; Ventura, K.; Zauderer, M.; Sauter, J.
Laboratory Investigation (2022)

Fulltext@MSK | Save

The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features

Journal Article

Schwartz, C. J.; Brogi, E.; Marra, A.; Da Cruz Paula, A. F.; Nanjangud, G. J.; da Silva, E. M.; Patil, S.; Shah, S.; Ventura, K.; Razavi, P.; more...
Modern Pathology (2022)

Fulltext@MSK | Save

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Journal Article

Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; more...
Journal of Hematology & Oncology (2021)

Fulltext@MSK | Save

Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma

Journal Article

Hoda, R. S.; Brogi, E.; Dos Anjos, C. H.; Grabenstetter, A.; Ventura, K.; Patil, S.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Traina, T.; more...
Modern Pathology (2020)

Fulltext@MSK | Save

Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≥4.0 and <6.0

Journal Article

Hoda, R. S.; Brogi, E.; Xu, J.; Ventura, K.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
Archives of Pathology & Laboratory Medicine (2020)

Fulltext@MSK | Save

Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system

Journal Article

Yoon, E. C.; Schwartz, C.; Brogi, E.; Ventura, K.; Wen, H.; Darvishian, F.
Breast Journal (2019)

Fulltext@MSK | Save

Clinicopathologic features of breast cancers with HER2/CEP17 ratio < 2, HER2 copy number ≥ 4 and < 6 signals/cell

Meeting Abstract

Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
Modern Pathology (2019)

Fulltext@MSK | Save

Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results

Meeting Abstract

Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
Modern Pathology (2019)

Fulltext@MSK | Save

Core needle biopsy diagnosis of fibroepithelial lesions: Features predictive of upgrade to phyllodes tumor at excision

Meeting Abstract

Salagean, E.; Ventura, K.; Brogi, E.; Murray, M.
Modern Pathology (2019)

Fulltext@MSK | Save